TY  - GEN
AU  - Cheng,A L
AU  - Hsu,C H
AU  - Lin,J K
AU  - Hsu,M M
AU  - Ho,Y F
AU  - Shen,T S
AU  - Ko,J Y
AU  - Lin,J T
AU  - Lin,B R
AU  - Ming-Shiang,W
AU  - Yu,H S
AU  - Jee,S H
AU  - Chen,G S
AU  - Chen,T M
AU  - Chen,C A
AU  - Lai,M K
AU  - Pu,Y S
AU  - Pan,M H
AU  - Wang,Y J
AU  - Tsai,C C
AU  - Hsieh,C Y
TI  - Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
SN  - 0250-7005
PY  - 2001///1210
KW  - Adult
KW  - Aged
KW  - Anticarcinogenic Agents
KW  - administration & dosage
KW  - Arsenicals
KW  - adverse effects
KW  - Bowen's Disease
KW  - chemically induced
KW  - Carcinoma, Transitional Cell
KW  - drug therapy
KW  - Curcumin
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Leukoplakia, Oral
KW  - Male
KW  - Metaplasia
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - prevention & control
KW  - Precancerous Conditions
KW  - Prospective Studies
KW  - Risk
KW  - Skin Neoplasms
KW  - Stomach
KW  - pathology
KW  - Stomach Neoplasms
KW  - Treatment Outcome
KW  - Urinary Bladder Neoplasms
KW  - Uterine Cervical Neoplasms
KW  - Uterine Cervical Dysplasia
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
ER  -